IntelGenx Technologies Corp. Share Price OTC Bulletin Board
Equities
IGX
US45822R1014
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
Sales 2022 | 10L 12.98L 7.92Cr | Sales 2023 | 10.39L 14.2L 8.67Cr | Capitalization | 2.41Cr 3.3Cr 201.22Cr |
---|---|---|---|---|---|
Net income 2022 | -1Cr -1.37Cr -83Cr | Net income 2023 | -90L -1.23Cr -75Cr | EV / Sales 2022 | 44.7 x |
Net Debt 2022 | 79.84L 1.09Cr 67Cr | Net Debt 2023 | 1.32Cr 1.81Cr 110.26Cr | EV / Sales 2023 | 35.9 x |
P/E ratio 2022 |
-2.82
x | P/E ratio 2023 |
-2.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.6% |
Latest transcript on IntelGenx Technologies Corp.
Managers | Title | Age | Since |
---|---|---|---|
Dwight Gorham
CEO | Chief Executive Officer | 66 | 13/23/13 |
André Godin
DFI | Director of Finance/CFO | 61 | 20/15/20 |
Horst Zerbe
CHM | Chairman | 77 | 01/06/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Horst Zerbe
CHM | Chairman | 77 | 01/06/01 |
Mark Nawacki
BRD | Director/Board Member | 54 | 09/16/09 |
Bernd Melchers
BRD | Director/Board Member | 72 | 08/09/08 |
1st Jan change | Capi. | |
---|---|---|
+20.40% | 4.38TCr | |
+30.16% | 2.28TCr | |
+20.18% | 1.56TCr | |
+18.49% | 1.43TCr | |
+54.83% | 1.3TCr | |
-0.05% | 678.76Cr | |
-11.72% | 641.27Cr | |
-8.87% | 572.55Cr | |
+14.65% | 568.66Cr |
- Stock Market
- Equities
- IGXT Stock
- IGX Stock